Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Equities researchers at Leerink Partnrs reduced their FY2029 earnings estimates for shares of Viridian Therapeutics in a research report issued on Wednesday, November 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will earn $1.32 per share for the year, down from their prior estimate […]

NAPCO Security Technologies, Inc. (NASDAQ:NSSC – Free Report) – Stock analysts at DA Davidson cut their FY2026 earnings per share estimates for shares of NAPCO Security Technologies in a research report issued to clients and investors on Wednesday, November 5th. DA Davidson analyst M. Summerville now forecasts that the industrial products company will post earnings […]

Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – HC Wainwright lifted their FY2026 earnings per share (EPS) estimates for shares of Esperion Therapeutics in a research note issued to investors on Thursday, November 6th. HC Wainwright analyst J. Pantginis now forecasts that the biopharmaceutical company will post earnings per share of $0.40 for the year, […]